1. Home
  2. THG vs BLCO Comparison

THG vs BLCO Comparison

Compare THG & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hanover Insurance Group Inc

THG

Hanover Insurance Group Inc

HOLD

Current Price

$176.73

Market Cap

6.2B

Sector

Finance

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$16.46

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THG
BLCO
Founded
1852
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Ophthalmic Goods
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
6.0B
IPO Year
1996
2022

Fundamental Metrics

Financial Performance
Metric
THG
BLCO
Price
$176.73
$16.46
Analyst Decision
Buy
Buy
Analyst Count
5
12
Target Price
$194.60
$18.45
AVG Volume (30 Days)
265.4K
417.4K
Earning Date
04-29-2026
04-29-2026
Dividend Yield
2.11%
N/A
EPS Growth
55.21
N/A
EPS
18.16
N/A
Revenue
$6,594,400,000.00
$5,101,000,000.00
Revenue This Year
$3.04
$8.63
Revenue Next Year
$4.24
$5.58
P/E Ratio
$9.89
N/A
Revenue Growth
5.72
6.47
52 Week Low
$155.93
$10.45
52 Week High
$188.18
$18.92

Technical Indicators

Market Signals
Indicator
THG
BLCO
Relative Strength Index (RSI) 55.62 49.85
Support Level $173.68 $16.35
Resistance Level $177.72 $16.81
Average True Range (ATR) 3.52 0.47
MACD 0.85 0.11
Stochastic Oscillator 60.43 72.63

Price Performance

Historical Comparison
THG
BLCO

About THG Hanover Insurance Group Inc

The Hanover Insurance Group Inc is a holding company whose primary business is offering property and casualty insurance products and services. The company markets itself through independent agents and brokers in the United States while conducting business through Hanover Insurance, Citizens and other THG subsidiaries. The company conducts business operations through four operating segments: Core Commercial, Specialty, Personal Lines, and Other. The company operates an investment portfolio that is exposed to fixed-income securities.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: